EQT Life Sciences Team
INVESTORSINTRO STRENGTHSWEET SPOT (RANGE)INVESTMENT LOCATIONSTOP INVESTMENT CATEGORIES
n/a
$25.0M
($11.0M - $65.0M)
Investors in Boston (MA)
Photo of Daniela Begolo, Managing Director at EQT Life Sciences
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Munich (Germany)
Photo of Christoph Broja, Managing Director at EQT Life Sciences
n/a
$25.0M
($11.0M - $65.0M)
Investors in Germany
n/a
$25.0M
($11.0M - $65.0M)
Investors in United Kingdom
n/a
$25.0M
($11.0M - $65.0M)
Investors in Belgium
Investors in BioTech (Series B)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
Photo of Laurenz Govaerts, Vice President at EQT Life Sciences
n/a
$25.0M
($11.0M - $65.0M)
Investors in Brussels
Photo of Sonia Hallen, Vice President at EQT Life Sciences
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Seed), Investors in BioTech (Pre-seed)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Oxford (United Kingdom)
Photo of Cillian King, Managing Director at EQT Life Sciences
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Series B), Investors in BioTech (Seed), Investors in Diverse Investors (Other Lists), Investors in BioTech (Series A)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Series A)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
n/a
$25.0M
($11.0M - $65.0M)
Investors in United Kingdom
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Munich (Germany)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Series B)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Seed), Investors in AI (Seed), Investors in Health IT (Pre-seed), Investors in Digital Health (Pre-seed), Investors in BioTech (Pre-seed), Investors in Health & Hospital Services (Pre-seed), Investors in AI (Pre-seed), Investors in Health IT (Seed), Investors in Digital Health (Seed), Investors in Health & Hospital Services (Seed)
+5
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
n/a
$25.0M
($11.0M - $65.0M)
Investors in Amsterdam (Netherlands)
Investors in BioTech (Seed), Investors in BioTech (Pre-seed)